Protein Drugs Market Report

China Protein Drugs Industry Market Research Report 2023-2029

  • POSTDATE：Aug 27, 2023
  • PAGES：179
  • REPORT CODE：GMM1760024
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Protein Drugs industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Allergan

    • Dendreon

    • Baxter healthcare

    • Eli lilly

    • Hoffman-la-roche

    • Mylan

    • Hospira

    • Amgen

    • Glaxosmithkline

    • Janssen-cilag

    • Kedrion biopharmaceuticals, spa

    • Ferring pharmaceuticals

    • Omrix biopharmaceuticals

    • Bristol-myers squibb

    • Lundbeck

    • Eisai

    • Medimmune

    • Alcon

    • Alexion pharmaceuticals

    • Affymax

    • Nabi biopharmaceuticals (now biota pharmaceuticals)

    • Novo nordisk

    • Protein sciences corporation

    • Bio products laboratory

    • Fresenius kabi

    • Octapharma pharmazeutika produktionsgesmbh

    • Bayer healthcare pharmaceuticals

    • Btg international

    • Kamada

    • Cangene

    • Merck

    • Csl

    • Pfizer

    • Abbott laboratories

    • Biotest pharmaceuticals

    • Boehringer ingelheim

    • Biogen

    By Type:

    • Blood products

    • Peptide hormones

    • Peptide antibiotics

    • Antibodies

    • Cytokines

    • Vaccines

    • Enzymes

    By Application:

    • Application 1

    • Application 2

    • Application 3

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Protein Drugs Market Overview 2018-2029

    • 1.1 China Protein Drugs Industry Development Overview

    • 1.2 China Protein Drugs Industry Development History

    • 1.3 China Protein Drugs Industry Market Size (2018-2029)

    • 1.4 China Protein Drugs Market Analysis by Type from Production Side

      • 1.4.1 China Protein Drugs Production Volume, Production Value and Growth Rate of Blood products (2018-2029)

      • 1.4.2 China Protein Drugs Production Volume, Production Value and Growth Rate of Peptide hormones (2018-2029)

      • 1.4.3 China Protein Drugs Production Volume, Production Value and Growth Rate of Peptide antibiotics (2018-2029)

      • 1.4.4 China Protein Drugs Production Volume, Production Value and Growth Rate of Antibodies (2018-2029)

      • 1.4.5 China Protein Drugs Production Volume, Production Value and Growth Rate of Cytokines (2018-2029)

      • 1.4.6 China Protein Drugs Production Volume, Production Value and Growth Rate of Vaccines (2018-2029)

      • 1.4.7 China Protein Drugs Production Volume, Production Value and Growth Rate of Enzymes (2018-2029)

    • 1.5 China Protein Drugs Market Analysis by Application from Consumption End

      • 1.5.1 China Protein Drugs Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)

      • 1.5.2 China Protein Drugs Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)

      • 1.5.3 China Protein Drugs Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)

    • 1.6 China Protein Drugs Market Analysis by Region

      • 1.6.1 North China Protein Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Protein Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Protein Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Protein Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Protein Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Protein Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Protein Drugs Market Size and Growth Rate from 2018-2029

    Chapter 2 China Protein Drugs Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Protein Drugs Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Protein Drugs Market Status and Competition Analysis in 2023

      • 2.2.3 China Protein Drugs Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Protein Drugs Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Protein Drugs Industry Development

    Chapter 3 Protein DrugsIndustry Chain Analysis

    • 3.1 Protein Drugs Industry Chain

    • 3.2 Protein Drugs Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Protein Drugs Market

    • 3.3 Protein Drugs Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Protein Drugs Market

    Chapter 4 China Protein Drugs Market, by Type

    • 4.1 China Protein Drugs Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Protein Drugs Total Production Volume and Growth Rate from Production Side

    • 4.5 China Protein Drugs Production Volume and Growth Rate, by Type

      • 4.5.1 China Protein Drugs Production Volume and Growth Rate of Blood products

      • 4.5.2 China Protein Drugs Production Volume and Growth Rate of Peptide hormones

      • 4.5.3 China Protein Drugs Production Volume and Growth Rate of Peptide antibiotics

      • 4.5.4 China Protein Drugs Production Volume and Growth Rate of Antibodies

      • 4.5.5 China Protein Drugs Production Volume and Growth Rate of Cytokines

      • 4.5.6 China Protein Drugs Production Volume and Growth Rate of Vaccines

      • 4.5.7 China Protein Drugs Production Volume and Growth Rate of Enzymes

    Chapter 5 China Protein Drugs Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Protein Drugs Total Market Size and Growth Rate from Consumption End

    • 5.5 China Protein Drugs Market Size and Growth Rate, by Application

      • 5.5.1 China Protein Drugs Market Size and Growth Rate of Application 1

      • 5.5.2 China Protein Drugs Market Size and Growth Rate of Application 2

      • 5.5.3 China Protein Drugs Market Size and Growth Rate of Application 3

    Chapter 6 China Protein Drugs Market, by Region

    • 6.1 China Protein Drugs Production Volume and Production Value, by Region

    • 6.2 China Protein Drugs Sales Volume and Sales Value, by Region

    Chapter 7 North China Protein Drugs Market Analysis

    • 7.1 North China Protein Drugs Market, by Type

    • 7.2 North China Protein Drugs Market, by Application

    Chapter 8 Central China Protein Drugs Market Analysis

    • 8.1 Central China Protein Drugs Market, by Type

    • 8.2 Central China Protein Drugs Market, by Application

    Chapter 9 South China Protein Drugs Market Analysis

    • 9.1 South China Protein Drugs Market, by Type

    • 9.2 South China Protein Drugs Market, by Application

    Chapter 10 East China Protein Drugs Market Analysis

    • 10.1 East China Protein Drugs Market, by Type

    • 10.2 East China Protein Drugs Market, by Application

    Chapter 11 Northeast China Protein Drugs Market Analysis

    • 11.1 Northeast China Protein Drugs Market, by Type

    • 11.2 Northeast China Protein Drugs Market, by Application

    Chapter 12 Southwest China Protein Drugs Market Analysis

    • 12.1 Southwest China Protein Drugs Market, by Type

    • 12.2 Southwest China Protein Drugs Market, by Application

    Chapter 13 Northwest China Protein Drugs Market Analysis

    • 13.1 Northwest China Protein Drugs Market, by Type

    • 13.2 Northwest China Protein Drugs Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Allergan

        • 14.1.1 Allergan Company Profile

        • 14.1.2 Allergan Protein Drugs Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Dendreon

        • 14.2.1 Dendreon Company Profile

        • 14.2.2 Dendreon Protein Drugs Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Baxter healthcare

        • 14.3.1 Baxter healthcare Company Profile

        • 14.3.2 Baxter healthcare Protein Drugs Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Eli lilly

        • 14.4.1 Eli lilly Company Profile

        • 14.4.2 Eli lilly Protein Drugs Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Hoffman-la-roche

        • 14.5.1 Hoffman-la-roche Company Profile

        • 14.5.2 Hoffman-la-roche Protein Drugs Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Mylan

        • 14.6.1 Mylan Company Profile

        • 14.6.2 Mylan Protein Drugs Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Hospira

        • 14.7.1 Hospira Company Profile

        • 14.7.2 Hospira Protein Drugs Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Amgen

        • 14.8.1 Amgen Company Profile

        • 14.8.2 Amgen Protein Drugs Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Glaxosmithkline

        • 14.9.1 Glaxosmithkline Company Profile

        • 14.9.2 Glaxosmithkline Protein Drugs Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Janssen-cilag

        • 14.10.1 Janssen-cilag Company Profile

        • 14.10.2 Janssen-cilag Protein Drugs Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Kedrion biopharmaceuticals, spa

        • 14.11.1 Kedrion biopharmaceuticals, spa Company Profile

        • 14.11.2 Kedrion biopharmaceuticals, spa Protein Drugs Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Ferring pharmaceuticals

        • 14.12.1 Ferring pharmaceuticals Company Profile

        • 14.12.2 Ferring pharmaceuticals Protein Drugs Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Omrix biopharmaceuticals

        • 14.13.1 Omrix biopharmaceuticals Company Profile

        • 14.13.2 Omrix biopharmaceuticals Protein Drugs Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 Bristol-myers squibb

        • 14.14.1 Bristol-myers squibb Company Profile

        • 14.14.2 Bristol-myers squibb Protein Drugs Market Performance

        • 14.14.3 Product&Service Introduction

      • 14.15 Lundbeck

        • 14.15.1 Lundbeck Company Profile

        • 14.15.2 Lundbeck Protein Drugs Market Performance

        • 14.15.3 Product&Service Introduction

      • 14.16 Eisai

        • 14.16.1 Eisai Company Profile

        • 14.16.2 Eisai Protein Drugs Market Performance

        • 14.16.3 Product&Service Introduction

      • 14.17 Medimmune

        • 14.17.1 Medimmune Company Profile

        • 14.17.2 Medimmune Protein Drugs Market Performance

        • 14.17.3 Product&Service Introduction

      • 14.18 Alcon

        • 14.18.1 Alcon Company Profile

        • 14.18.2 Alcon Protein Drugs Market Performance

        • 14.18.3 Product&Service Introduction

      • 14.19 Alexion pharmaceuticals

        • 14.19.1 Alexion pharmaceuticals Company Profile

        • 14.19.2 Alexion pharmaceuticals Protein Drugs Market Performance

        • 14.19.3 Product&Service Introduction

      • 14.20 Affymax

        • 14.20.1 Affymax Company Profile

        • 14.20.2 Affymax Protein Drugs Market Performance

        • 14.20.3 Product&Service Introduction

      • 14.21 Nabi biopharmaceuticals (now biota pharmaceuticals)

        • 14.21.1 Nabi biopharmaceuticals (now biota pharmaceuticals) Company Profile

        • 14.21.2 Nabi biopharmaceuticals (now biota pharmaceuticals) Protein Drugs Market Performance

        • 14.21.3 Product&Service Introduction

      • 14.22 Novo nordisk

        • 14.22.1 Novo nordisk Company Profile

        • 14.22.2 Novo nordisk Protein Drugs Market Performance

        • 14.22.3 Product&Service Introduction

      • 14.23 Protein sciences corporation

        • 14.23.1 Protein sciences corporation Company Profile

        • 14.23.2 Protein sciences corporation Protein Drugs Market Performance

        • 14.23.3 Product&Service Introduction

      • 14.24 Bio products laboratory

        • 14.24.1 Bio products laboratory Company Profile

        • 14.24.2 Bio products laboratory Protein Drugs Market Performance

        • 14.24.3 Product&Service Introduction

      • 14.25 Fresenius kabi

        • 14.25.1 Fresenius kabi Company Profile

        • 14.25.2 Fresenius kabi Protein Drugs Market Performance

        • 14.25.3 Product&Service Introduction

      • 14.26 Octapharma pharmazeutika produktionsgesmbh

        • 14.26.1 Octapharma pharmazeutika produktionsgesmbh Company Profile

        • 14.26.2 Octapharma pharmazeutika produktionsgesmbh Protein Drugs Market Performance

        • 14.26.3 Product&Service Introduction

      • 14.27 Bayer healthcare pharmaceuticals

        • 14.27.1 Bayer healthcare pharmaceuticals Company Profile

        • 14.27.2 Bayer healthcare pharmaceuticals Protein Drugs Market Performance

        • 14.27.3 Product&Service Introduction

      • 14.28 Btg international

        • 14.28.1 Btg international Company Profile

        • 14.28.2 Btg international Protein Drugs Market Performance

        • 14.28.3 Product&Service Introduction

      • 14.29 Kamada

        • 14.29.1 Kamada Company Profile

        • 14.29.2 Kamada Protein Drugs Market Performance

        • 14.29.3 Product&Service Introduction

      • 14.30 Cangene

        • 14.30.1 Cangene Company Profile

        • 14.30.2 Cangene Protein Drugs Market Performance

        • 14.30.3 Product&Service Introduction

      • 14.31 Merck

        • 14.31.1 Merck Company Profile

        • 14.31.2 Merck Protein Drugs Market Performance

        • 14.31.3 Product&Service Introduction

      • 14.32 Csl

        • 14.32.1 Csl Company Profile

        • 14.32.2 Csl Protein Drugs Market Performance

        • 14.32.3 Product&Service Introduction

      • 14.33 Pfizer

        • 14.33.1 Pfizer Company Profile

        • 14.33.2 Pfizer Protein Drugs Market Performance

        • 14.33.3 Product&Service Introduction

      • 14.34 Abbott laboratories

        • 14.34.1 Abbott laboratories Company Profile

        • 14.34.2 Abbott laboratories Protein Drugs Market Performance

        • 14.34.3 Product&Service Introduction

      • 14.35 Biotest pharmaceuticals

        • 14.35.1 Biotest pharmaceuticals Company Profile

        • 14.35.2 Biotest pharmaceuticals Protein Drugs Market Performance

        • 14.35.3 Product&Service Introduction

      • 14.36 Boehringer ingelheim

        • 14.36.1 Boehringer ingelheim Company Profile

        • 14.36.2 Boehringer ingelheim Protein Drugs Market Performance

        • 14.36.3 Product&Service Introduction

      • 14.37 Biogen

        • 14.37.1 Biogen Company Profile

        • 14.37.2 Biogen Protein Drugs Market Performance

        • 14.37.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Protein Drugs Industry Research Conclusions

    • 15.2 Protein Drugs Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Protein Drugs Industry Market Size (2018-2029)

    • Figure China Protein Drugs Production Volume, Production Value and Growth Rate of Blood products (2018-2029)

    • Figure China Protein Drugs Production Volume, Production Value and Growth Rate of Peptide hormones (2018-2029)

    • Figure China Protein Drugs Production Volume, Production Value and Growth Rate of Peptide antibiotics (2018-2029)

    • Figure China Protein Drugs Production Volume, Production Value and Growth Rate of Antibodies (2018-2029)

    • Figure China Protein Drugs Production Volume, Production Value and Growth Rate of Cytokines (2018-2029)

    • Figure China Protein Drugs Production Volume, Production Value and Growth Rate of Vaccines (2018-2029)

    • Figure China Protein Drugs Production Volume, Production Value and Growth Rate of Enzymes (2018-2029)

    • Figure China Protein Drugs Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)

    • Figure China Protein Drugs Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)

    • Figure China Protein Drugs Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)

    • Figure North China Protein Drugs Market Size and Growth Rate from 2018-2029

    • Figure Central China Protein Drugs Market Size and Growth Rate from 2018-2029

    • Figure South China Protein Drugs Market Size and Growth Rate from 2018-2029

    • Figure East China Protein Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Protein Drugs Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Protein Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Protein Drugs Market Size and Growth Rate from 2018-2029

    • Figure Protein Drugs Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Protein Drugs Market Share by Type in 2018

    • Figure China Protein Drugs Market Share by Type in 2023

    • Figure China Protein Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Protein Drugs Production Volume and Growth Rate of Blood products (2018-2023)

    • Figure China Protein Drugs Production Volume and Growth Rate of Peptide hormones (2018-2023)

    • Figure China Protein Drugs Production Volume and Growth Rate of Peptide antibiotics (2018-2023)

    • Figure China Protein Drugs Production Volume and Growth Rate of Antibodies (2018-2023)

    • Figure China Protein Drugs Production Volume and Growth Rate of Cytokines (2018-2023)

    • Figure China Protein Drugs Production Volume and Growth Rate of Vaccines (2018-2023)

    • Figure China Protein Drugs Production Volume and Growth Rate of Enzymes (2018-2023)

    • Figure China Protein Drugs Market Share by Application in 2018

    • Figure China Protein Drugs Market Share by Application in 2023

    • Figure China Protein Drugs Total Market Size and Growth Rate from Consumption End

    • Figure China Protein Drugs Market Size and Growth Rate of Application 1 (2018-2023)

    • Figure China Protein Drugs Market Size and Growth Rate of Application 2 (2018-2023)

    • Figure China Protein Drugs Market Size and Growth Rate of Application 3 (2018-2023)

    • Table China Protein Drugs Production Volume by Region (2018-2023)

    • Table China Protein Drugs Production Volume Share by Region (2018-2023)

    • Figure China Protein Drugs Production Volume Share by Region (2018-2023)

    • Table China Protein Drugs Production Value by Region (2018-2023)

    • Table China Protein Drugs Production Value Share by Region (2018-2023)

    • Figure China Protein Drugs Production Value Share by Region (2018-2023)

    • Table China Protein Drugs Sales Volume by Region (2018-2023)

    • Table China Protein Drugs Sales Volume Share by Region (2018-2023)

    • Figure China Protein Drugs Sales Volume Share by Region (2018-2023)

    • Table China Protein Drugs Sales Value by Region (2018-2023)

    • Table China Protein Drugs Sales Value Share by Region (2018-2023)

    • Figure China Protein Drugs Sales Value Share by Region (2018-2023)

    • Table North China Protein Drugs Production Volume by Type (2018-2023)

    • Table North China Protein Drugs Production Volume Share by Type (2018-2023)

    • Figure North China Protein Drugs Production Volume Share by Type (2018-2023)

    • Table North China Protein Drugs Sales Volume by Application (2018-2023)

    • Table North China Protein Drugs Sales Volume Share by Application (2018-2023)

    • Figure North China Protein Drugs Sales Volume Share by Application (2018-2023)

    • Table Central China Protein Drugs Production Volume by Type (2018-2023)

    • Table Central China Protein Drugs Production Volume Share by Type (2018-2023)

    • Figure Central China Protein Drugs Production Volume Share by Type (2018-2023)

    • Table Central China Protein Drugs Sales Volume by Application (2018-2023)

    • Table Central China Protein Drugs Sales Volume Share by Application (2018-2023)

    • Figure Central China Protein Drugs Sales Volume Share by Application (2018-2023)

    • Table South China Protein Drugs Production Volume by Type (2018-2023)

    • Table South China Protein Drugs Production Volume Share by Type (2018-2023)

    • Figure South China Protein Drugs Production Volume Share by Type (2018-2023)

    • Table South China Protein Drugs Sales Volume by Application (2018-2023)

    • Table South China Protein Drugs Sales Volume Share by Application (2018-2023)

    • Figure South China Protein Drugs Sales Volume Share by Application (2018-2023)

    • Table East China Protein Drugs Production Volume by Type (2018-2023)

    • Table East China Protein Drugs Production Volume Share by Type (2018-2023)

    • Figure East China Protein Drugs Production Volume Share by Type (2018-2023)

    • Table East China Protein Drugs Sales Volume by Application (2018-2023)

    • Table East China Protein Drugs Sales Volume Share by Application (2018-2023)

    • Figure East China Protein Drugs Sales Volume Share by Application (2018-2023)

    • Table Northeast China Protein Drugs Production Volume by Type (2018-2023)

    • Table Northeast China Protein Drugs Production Volume Share by Type (2018-2023)

    • Figure Northeast China Protein Drugs Production Volume Share by Type (2018-2023)

    • Table Northeast China Protein Drugs Sales Volume by Application (2018-2023)

    • Table Northeast China Protein Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Protein Drugs Sales Volume Share by Application (2018-2023)

    • Table Southwest China Protein Drugs Production Volume by Type (2018-2023)

    • Table Southwest China Protein Drugs Production Volume Share by Type (2018-2023)

    • Figure Southwest China Protein Drugs Production Volume Share by Type (2018-2023)

    • Table Southwest China Protein Drugs Sales Volume by Application (2018-2023)

    • Table Southwest China Protein Drugs Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Protein Drugs Sales Volume Share by Application (2018-2023)

    • Table Northwest China Protein Drugs Production Volume by Type (2018-2023)

    • Table Northwest China Protein Drugs Production Volume Share by Type (2018-2023)

    • Figure Northwest China Protein Drugs Production Volume Share by Type (2018-2023)

    • Table Northwest China Protein Drugs Sales Volume by Application (2018-2023)

    • Table Northwest China Protein Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Protein Drugs Sales Volume Share by Application (2018-2023)

    • Table Allergan Company Profile

    • Table Allergan Protein Drugs Revenue, Price and Gross (2018-2023)

    • Table Dendreon Company Profile

    • Table Dendreon Protein Drugs Revenue, Price and Gross (2018-2023)

    • Table Baxter healthcare Company Profile

    • Table Baxter healthcare Protein Drugs Revenue, Price and Gross (2018-2023)

    • Table Eli lilly Company Profile

    • Table Eli lilly Protein Drugs Revenue, Price and Gross (2018-2023)

    • Table Hoffman-la-roche Company Profile

    • Table Hoffman-la-roche Protein Drugs Revenue, Price and Gross (2018-2023)

    • Table Mylan Company Profile

    • Table Mylan Protein Drugs Revenue, Price and Gross (2018-2023)

    • Table Hospira Company Profile

    • Table Hospira Protein Drugs Revenue, Price and Gross (2018-2023)

    • Table Amgen Company Profile

    • Table Amgen Protein Drugs Revenue, Price and Gross (2018-2023)

    • Table Glaxosmithkline Company Profile

    • Table Glaxosmithkline Protein Drugs Revenue, Price and Gross (2018-2023)

    • Table Janssen-cilag Company Profile

    • Table Janssen-cilag Protein Drugs Revenue, Price and Gross (2018-2023)

    • Table Kedrion biopharmaceuticals, spa Company Profile

    • Table Kedrion biopharmaceuticals, spa Protein Drugs Revenue, Price and Gross (2018-2023)

    • Table Ferring pharmaceuticals Company Profile

    • Table Ferring pharmaceuticals Protein Drugs Revenue, Price and Gross (2018-2023)

    • Table Omrix biopharmaceuticals Company Profile

    • Table Omrix biopharmaceuticals Protein Drugs Revenue, Price and Gross (2018-2023)

    • Table Bristol-myers squibb Company Profile

    • Table Bristol-myers squibb Protein Drugs Revenue, Price and Gross (2018-2023)

    • Table Lundbeck Company Profile

    • Table Lundbeck Protein Drugs Revenue, Price and Gross (2018-2023)

    • Table Eisai Company Profile

    • Table Eisai Protein Drugs Revenue, Price and Gross (2018-2023)

    • Table Medimmune Company Profile

    • Table Medimmune Protein Drugs Revenue, Price and Gross (2018-2023)

    • Table Alcon Company Profile

    • Table Alcon Protein Drugs Revenue, Price and Gross (2018-2023)

    • Table Alexion pharmaceuticals Company Profile

    • Table Alexion pharmaceuticals Protein Drugs Revenue, Price and Gross (2018-2023)

    • Table Affymax Company Profile

    • Table Affymax Protein Drugs Revenue, Price and Gross (2018-2023)

    • Table Nabi biopharmaceuticals (now biota pharmaceuticals) Company Profile

    • Table Nabi biopharmaceuticals (now biota pharmaceuticals) Protein Drugs Revenue, Price and Gross (2018-2023)

    • Table Novo nordisk Company Profile

    • Table Novo nordisk Protein Drugs Revenue, Price and Gross (2018-2023)

    • Table Protein sciences corporation Company Profile

    • Table Protein sciences corporation Protein Drugs Revenue, Price and Gross (2018-2023)

    • Table Bio products laboratory Company Profile

    • Table Bio products laboratory Protein Drugs Revenue, Price and Gross (2018-2023)

    • Table Fresenius kabi Company Profile

    • Table Fresenius kabi Protein Drugs Revenue, Price and Gross (2018-2023)

    • Table Octapharma pharmazeutika produktionsgesmbh Company Profile

    • Table Octapharma pharmazeutika produktionsgesmbh Protein Drugs Revenue, Price and Gross (2018-2023)

    • Table Bayer healthcare pharmaceuticals Company Profile

    • Table Bayer healthcare pharmaceuticals Protein Drugs Revenue, Price and Gross (2018-2023)

    • Table Btg international Company Profile

    • Table Btg international Protein Drugs Revenue, Price and Gross (2018-2023)

    • Table Kamada Company Profile

    • Table Kamada Protein Drugs Revenue, Price and Gross (2018-2023)

    • Table Cangene Company Profile

    • Table Cangene Protein Drugs Revenue, Price and Gross (2018-2023)

    • Table Merck Company Profile

    • Table Merck Protein Drugs Revenue, Price and Gross (2018-2023)

    • Table Csl Company Profile

    • Table Csl Protein Drugs Revenue, Price and Gross (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer Protein Drugs Revenue, Price and Gross (2018-2023)

    • Table Abbott laboratories Company Profile

    • Table Abbott laboratories Protein Drugs Revenue, Price and Gross (2018-2023)

    • Table Biotest pharmaceuticals Company Profile

    • Table Biotest pharmaceuticals Protein Drugs Revenue, Price and Gross (2018-2023)

    • Table Boehringer ingelheim Company Profile

    • Table Boehringer ingelheim Protein Drugs Revenue, Price and Gross (2018-2023)

    • Table Biogen Company Profile

    • Table Biogen Protein Drugs Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US